ACRS
Aclaris Therapeutics Inc
5.40$
+2.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.3% | 36.6% | 76.7% | 69.0% | 55.4% | 101.0% | 34.8% | 104.1% | 16.3% | -62.0% | 19.8% | 14.2% | 4.4% | |
| 11.7% | 63.4% | 23.3% | 31.0% | 44.6% | -1.0% | 65.2% | -4.1% | 83.7% | 162.0% | 80.2% | 85.8% | 95.6% | |
| 257.2% | 151.7% | 410.6% | 316.7% | 137.0% | 98.0% | 796.2% | 644.3% | 394.9% | 1,280.6% | 784.4% | 1,157.2% | 780.1% | |
| 73.2% | 46.8% | 285.4% | 171.8% | 130.1% | 53.8% | 421.9% | 303.1% | 147.7% | 430.6% | 337.8% | 371.3% | 282.7% | |
| 351.9% | 86.4% | 812.7% | 495.7% | 285.5% | 1,081.2% | 1,308.1% | 1,031.8% | 603.5% | 1,917.5% | 1,192.0% | 1,573.7% | 1,145.8% | |
| -340.2% | -23.0% | -789.4% | -464.7% | -240.9% | -1,082.1% | -1,242.9% | -1,035.9% | -519.8% | -1,755.5% | -1,111.8% | -1,487.9% | -1,050.2% | |
| – | 9.1% | – | – | – | 44.4% | – | – | – | – | – | – | – | |
| -315.2% | -10.6% | -706.5% | -397.2% | -174.6% | -1,048.2% | -1,036.8% | -868.3% | -443.0% | -1,528.6% | -993.2% | -1,320.1% | -921.5% | |
| -2.4% | -2.1% | 8.3% | – | -174.6% | – | – | – | – | – | – | – | – | |
| -315.2% | -8.5% | -706.5% | -397.2% | -174.6% | -1,048.2% | -1,036.8% | -868.3% | -443.0% | -1,528.6% | -993.2% | -1,320.1% | -921.5% | |
| -316.4% | -134.3% | -662.6% | -456.0% | -218.4% | -151.2% | -1,213.5% | -945.1% | -436.6% | -1,520.7% | -988.1% | -1,307.3% | -913.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.